Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1/Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22
/vufind/Search/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22
Search /vufind/Search2/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22
PubPharm (8.800)
1
Clinical Trial of Perispinal Etanercept Treatment for Stroke patients to examine the effect on fatigue and muscle spasticity. : Placebo-controlled randomized Clinical Trial of Perispinal Etanercept in Australian patients with chronic stroke 2020: Fatigue & muscle spasticity study (PSE-2020).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Clinical Trial of Perispinal Etanercept Treatment for Stroke patients to examine the effect on fatigue and muscle spasticity. : Placebo-controlled randomized Clinical Trial of Perispinal Etanercept in Australian patients with chronic stroke 2020: Fatigue & muscle spasticity study (PSE-2020).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
NEPTUNE: Determining the safety and assessing the effectiveness of combining avelumab and radium-223 in patients with breast cancer which has spread to the bones : NEPTUNE: Enhancement of immuNothEraPy combining avelumab and repeaT doses of radiUm-223 in ER+ve, HER2-ve metastatic breast caNcEr
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Cell therapy clinical trial of BOXR1030 in GPC3 positive liver, squamous lung, Merkel cell cancer, and myxoid/round cell liposarcoma : A first-in-human, phase 1/2, dose escalation study of BOXR1030 T cells in subjects with advanced GPC3-positive solid tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A phase I/II open-label platform study to evaluate the safety and efficacy of multiple amivantamab-based therapeutic combinations in participants with advanced, unresectable lung cancer : A phase I/II open-label platform study to evaluate the safety and efficacy of multiple amivantamab-based therapeutic combinations in participants with advanced, unresectable lung cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
NEPTUNE: Determining the safety and assessing the effectiveness of combining avelumab and radium-223 in patients with breast cancer which has spread to the bones : NEPTUNE: Enhancement of immuNothEraPy combining avelumab and repeaT doses of radiUm-223 in ER+ve, HER2-ve metastatic breast caNcEr
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Cell therapy clinical trial of BOXR1030 in GPC3 positive liver, squamous lung, Merkel cell cancer, and myxoid/round cell liposarcoma : A first-in-human, phase 1/2, dose escalation study of BOXR1030 T cells in subjects with advanced GPC3-positive solid tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A phase I/II open-label platform study to evaluate the safety and efficacy of multiple amivantamab-based therapeutic combinations in participants with advanced, unresectable lung cancer : A phase I/II open-label platform study to evaluate the safety and efficacy of multiple amivantamab-based therapeutic combinations in participants with advanced, unresectable lung cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
AMLM26/T5 INTERCEPT: A multi-arm trial for patients with acute myeloid leukaemia investigating new treatments which target early relapse and changes in disease characteristics - MBG453 OR MBG453 and Azacitidine : AMLM26/T5- INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in Acute Myeloid Leukaemia (AML)): A Multi-arm, Precision-based, Recursive, Platform Trial - MBG453 OR MBG453 and Azacitidine
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Phase I/II study to assess the safety and efficacy of full-spectrum medicinal cannabis plant extract 0.08% THC (NTI164) in the treatment of Rett syndrome (RTT) : A Phase I/II study to assess the safety and efficacy of full-spectrum medicinal cannabis plant extract 0.08% THC (NTI164) in the treatment of Rett syndrome (RTT) in female patients aged 5 to 20 years.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[880]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1/Phase 2
Medienart
8.800
Aufsätze
8.800
E-Artikel
8.800
E-Ressourcen
Zeitschriftentitel
8.800
WHO International Clinical Trials Registry Plat...
Thema
8.800
610
Phase: Phase 1/Phase 2
8.368
Study Type: Interventional
2.440
Recruitment Status: Recruiting
2.300
Recruitment Status: Completed
2.238
Recruitment Status: Not yet recruiting
1.030
Recruitment Status: Complete: follow-up complete
384
Study Type: Observational
198
Recruitment Status: Complete: follow-up continuing
124
Medical Condition: ;Neoplasms
96
Recruitment Status: Closed to Recruitment of Pa...
86
Recruitment Status: Active, not recruiting
64
Recruitment Status: Stopped early
46
Recruitment Status: Suspended
40
Recruitment Status: Enrolling by invitation
34
Recruitment Status: Terminated
30
Recruitment Status: Withdrawn
28
Medical Condition: Breast cancer
28
Medical Condition: Health Condition 1: O- Medic...
28
Recruitment Status: Other
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7.524
2020-
1.276
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8.612
Englisch
168
Unbestimmt
6
Nyanja
4
Kinyarwanda
4
Portugiesisch
4
Sanskrit
2
Quechua
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...